In this interview, Zamas Lam (QPS; DE, USA) discusses various methods that can be used to quantify oligonucleotide drugs and the progress that has been made to regulate and standardize oligonucleotide analysis in recent years.
In this interview, Stephanie Traub (Cancer Research UK; London, UK) discusses her work as a biomarker specialist and the challenges she faces when developing biomarker strategies.
In this interview, Annick De Vries (Sanquin; Amsterdam, Netherlands) discusses how personalized sampling can be utilised to achieve optimal PK/PD data, and how PK measurements translate into real life.
In this interview, David Harris (Charles River Laboratories; NC, USA) discusses the current global landscape for cell therapy, associated safety concerns and challenges, and preclinical animal models that are used to evaluate cellular therapies.
Discover more about how Charles River (MA, USA) employs flow cytometry to support mouse model development in this interview with Christoph Eberle and Stephen Festin.
Discover more about the development of CAR-T cell therapies, their bioanalytical challenges and specialized antibody reagents that can be ustilized to overcome these in this interview with Michael Schwenkert (Bio-Rad Laboratories; Germany).
The 2019 Bioanalysis Rising Star Award finalists have been announced! Meet Xiaoyu Wang (Nanjing University, China) your 2019 BRSA finalist.
The 2019 Bioanalysis Rising Star Award finalists have been announced! Meet Sebastien Boridy (Charles River Laboratories, Montreal, Canada) your 2019 BRSA finalist.
The 2019 Bioanalysis Rising Star Award finalists have been announced! Meet Lee Andrews (Syneos Health, NC, USA) your 2019 BRSA finalist.